This review discusses the difficulties associated with diagnosis and treatment of median arcuate ligament syndrome and provides an algorithm to guide workup and intervention.
This observational study evaluates the results obtained in a population of patients with Crohn disease who have undergone side-to-side isoperistaltic strictureplasty.
This Special Communication describes evidence-based guidelines to enhance the appropriate, safe, and effective practice of parathyroidectomy.
This narrative review summarizes recent advances in the management of localized pancreatic cancer, including the rationale for neoadjuvant treatment sequencing and new diagnostic biomarkers in development.
This case series describes outcomes for patients with borderline resectable pancreatic cancer treated with preoperative chemotherapy, and the details of how collaborating Oncology Study Groups coordinated and conducted the study.
This study uses data from the Vascular Study Group of New England data registry to compare postoperative complication and long-term survival rates in patients who received general anesthesia with those who received combined epidural and general anesthesia for elective abdominal aortic aneurysm repair.
An active man in his early 80s presented to the hospital with a 6-month history of cramping epigastric abdominal pain that occurred 30 minutes after eating solid food and was associated with nausea and vomiting. His medical history was significant for atrial fibrillation and a history of an open abdominal aortic aneurysm repair. What is your diagnosis?
This cohort study evaluates the effect of an endovascular-first protocol for patients with a ruptured abdominal aortic aneurysm on perioperative mortality and associated early clinical outcomes.
This randomized clinical trial demonstrates that Ivor-Lewis esophagectomy can be performed with lower rates of postoperative complications and more lymph node retrieval compared with Sweet esophagectomy.
Kadera and colleagues aimed to perform a detailed survival analysis of their institution’s experience with patients with locally advanced/borderline resectable pancreatic ductal adenocarcinoma who were downstaged and underwent surgical resection and (2) identify prognostic biomarkers that may help guide a decision for the use of adjuvant therapy in this patient subgroup. L. Andrew DiFronzo, MD, provided an invited commentary.